Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H16F2N2 |
Molecular Weight | 346.3726 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=C(F)C=CC=C4
InChI
InChIKey=QHMWCHQXCUNUAK-UHFFFAOYSA-N
InChI=1S/C22H16F2N2/c23-19-12-10-18(11-13-19)22(26-15-14-25-16-26,17-6-2-1-3-7-17)20-8-4-5-9-21(20)24/h1-16H
Molecular Formula | C22H16F2N2 |
Molecular Weight | 346.3726 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.drugs.com/international/flutrimazole.html | https://www.ncbi.nlm.nih.gov/pubmed/8569815 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/197.pdf | https://www.ncbi.nlm.nih.gov/pubmed/21718579
Curator's Comment: description was created based on several sources, including
https://www.drugs.com/international/flutrimazole.html | https://www.ncbi.nlm.nih.gov/pubmed/8569815 | https://www.old.health.gov.il/units/pharmacy/trufot/alonim/197.pdf | https://www.ncbi.nlm.nih.gov/pubmed/21718579
Flutrimazole (trade names Flusporan, Funcenal, Micetal, Topiderm) is an imidazole derivative, a wide-spectrum antifungal drug used for the topical treatment of superficial mycoses of the skin. Flutrimazole interferes with the synthesis of ergosterol by inhibiting the activity of the enzyme lanosterol 14 α-demethylase. Flutrimazole’s antifungal activity has been demonstrated in in vivo and in vitro studies to be comparable to that of clotrimazole and higher than bifonazole. During clinical trials the incidence of adverse reactions in relation to the use of Flutrimazole skin cream was 8%, being the most frequent those described as slight burning, irritation, itching, and erythema in the area of application.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3307221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1418042 |
|||
Target ID: CHEMBL2047 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23688559 |
13.8 µM [IC50] | ||
Target ID: CHEMBL3401 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23688559 |
6.1 µM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Flutrimazole Approved UseFLUSPORAN dermal cream is indicated for the topical treatment of superficial mycoses of the skin, such as ringworm in its varieties: tinea pedis (athlete's foot), tinea cruris, tinea corporis, tinea faciei et barbae and tinea inguinalis , caused by Trichophyton (eg T. rubrum, T. mentagrophytes, T. tonsurans), Microsporum (eg M. canis, M. gypseum) and Epidermophyton floccosum . In the treatment of cutaneous candidiasis mainly produced by yeasts of the genus Candida (eg C. albicans, C. parapsilosis, C. guillermondi, C. tropicalis). It is also indicated for the treatment of pityriasis versicolor caused by Malassezia furfur or also known as Pityrosporum ovale. |
|||
Primary | Flutrimazole Approved UseFLUSPORAN dermal cream is indicated for the topical treatment of superficial mycoses of the skin, such as ringworm in its varieties: tinea pedis (athlete's foot), tinea cruris, tinea corporis, tinea faciei et barbae and tinea inguinalis , caused by Trichophyton (eg T. rubrum, T. mentagrophytes, T. tonsurans), Microsporum (eg M. canis, M. gypseum) and Epidermophyton floccosum . In the treatment of cutaneous candidiasis mainly produced by yeasts of the genus Candida (eg C. albicans, C. parapsilosis, C. guillermondi, C. tropicalis). It is also indicated for the treatment of pityriasis versicolor caused by Malassezia furfur or also known as Pityrosporum ovale. |
|||
Primary | Flutrimazole Approved UseFLUSPORAN dermal cream is indicated for the topical treatment of superficial mycoses of the skin, such as ringworm in its varieties: tinea pedis (athlete's foot), tinea cruris, tinea corporis, tinea faciei et barbae and tinea inguinalis , caused by Trichophyton (eg T. rubrum, T. mentagrophytes, T. tonsurans), Microsporum (eg M. canis, M. gypseum) and Epidermophyton floccosum . In the treatment of cutaneous candidiasis mainly produced by yeasts of the genus Candida (eg C. albicans, C. parapsilosis, C. guillermondi, C. tropicalis). It is also indicated for the treatment of pityriasis versicolor caused by Malassezia furfur or also known as Pityrosporum ovale. |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21718579
1 g for 7 days
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8569815
A total of 23 M. furfur isolates were tested for susceptibility to the various azole antifungal agents in vitro. The isolates all came originally from clinical samples and had been maintained at – 70 C with glycerol as cryoprotectant. Inocula were prepared as 4-day static cultures in Dixon broth incubated at 37 C. The suspensions were diluted with sterile water so that a l0-fold dilution gave an OD of 0.1 at 530 nm. A 25-loop multiple inoculating device was used to place volumes of approximately 30 mkl on the test media (Flutrimazole). The cultures were incubated at 37 C for 4 days and minimum inhibitory concentrations (MICs) were recorded as the lowest concentrations at which no growth of M. furfur was visible.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:10:21 GMT 2023
by
admin
on
Fri Dec 15 17:10:21 GMT 2023
|
Record UNII |
776S0UP252
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
G01AF18
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
||
|
WHO-VATC |
QD01AC16
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
||
|
WHO-VATC |
QG01AF18
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
||
|
WHO-ATC |
D01AC16
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3401
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
DB13425
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107430
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
SUB07765MIG
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
100000080406
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
776S0UP252
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
C167003
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
DTXSID30869622
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
1227
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
82864
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
6460
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
61773
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
Flutrimazole
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
119006-77-8
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
C076986
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | |||
|
m5513
Created by
admin on Fri Dec 15 17:10:21 GMT 2023 , Edited by admin on Fri Dec 15 17:10:21 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |